Stock profile

Demant A/S(DEMANT.CO)

Country: DenmarkSector: HealthcareIndustry: Medical - DevicesExchange: CPH
P/E TTM
14.9
History
P/E NTM
21.0
Market cap
57.36B
Currency DKK
KvantraRanki37
Value40
Quality25
Momentum48
Current price
284.20+2.60%
Benchmarks

No price history available.

Key financial summary

Financials in DKK
202020212022202320242025TTM2026E
Total revenueDKKm14,46918,38819,70522,44322,41923,079N/AN/A
Operating profitDKKmLockedLockedLockedLockedLockedLockedLockedLocked
Net profitDKKm1,1212,5132,0821,7952,3871,545N/AN/A
EPS reportedDKKLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareDKKLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareDKKLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareDKKLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flowDKKmLockedLockedLockedLockedLockedLockedLockedLocked
Net debtDKKmLockedLockedLockedLockedLockedLockedLockedLocked
Book value equityDKKmLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareDKKLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)DKKLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in DKK
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Demant A/S operates as a prominent international entity within the hearing health and audio technology sectors, extending its reach across Europe, North America, the Pacific region, and Asia. The company's activities are structured into two core divisions: Hearing Healthcare and Communications. The Hearing Healthcare segment focuses on the development, sale, and support of hearing aids, in addition to offering a range of diagnostic tools and associated services. Conversely, the Communications segment delivers headsets for professional contact centers, general office environments, and the gaming industry, all distributed under the EPOS brand. Established in 1904, Demant A/S, which was formerly known as William Demant Holding A/S until its name change in March 2019, maintains its corporate headquarters in Smørum, Denmark.

SectorHealthcare
IndustryMedical - Devices
CountryDenmark
Trades inDKK

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Demant A/S (DEMANT.CO)

DEMANT.CO · CPH · Healthcare
284.20+2.60%
Sign up to track this stock

No price history available.

KvantraRank37
P/E TTM14.9
P/E NTM21.0
Market cap57.36B
KvantraRank37 / 100
Value
40
Quality
25
Momentum
48
Financialsin DKK
20242025TTM2026E
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Demant A/S operates as a prominent international entity within the hearing health and audio technology sectors, extending its reach across Europe, North America, the Pacific region, and Asia. The company's activities are structured into two core divisions: Hearing Healthcare and Communications. The Hearing Healthcare segment focuses on the development, sale, and support of hearing aids, in addition to offering a range of diagnostic tools and associated services. Conversely, the Communications segment delivers headsets for professional contact centers, general office environments, and the gaming industry, all distributed under the EPOS brand. Established in 1904, Demant A/S, which was formerly known as William Demant Holding A/S until its name change in March 2019, maintains its corporate headquarters in Smørum, Denmark.

SectorHealthcare
IndustryMedical - Devices
CountryDenmark
Trades inDKK

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans